LibGuides: Dignity Health Libraries COVID-19 Portal: C-19 Research

Research Resources

Retraction Watch: Retracted coronavirus (COVID-19) papers

Critical Appraisal of COVID-19 Research

Important COVID-19 Research Articles

WHO recommends highly successful COVID-19 therapy and calls for wide geographical distribution and transparency from originator (WHO 4/22/22)
Scripps Research discovery could enable broad coronavirus vaccine (Scripps Research 2/10/22, incl. Video 1:18)
Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities (JAMA Internal Medicine 2/18/22)
Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine (JAMA Internal Medicine 11/30/21)
COVID-19–Associated Deaths After SARS-CoV-2 Infection During Pregnancy — Mississippi, March 1, 2020–October 6, 2021 (MMWR 11/19/21)
Risk for Stillbirth Among Women With and Without COVID-19 at Delivery Hospitalization — United States, March 2020–September 2021 (MMWR 11/19/21)
COVID-19 Science Update (CDC Office of Library Science weekly series)

SARS-CoV-2 detection in different respiratory sites: A systematic review and meta-analysis (Lancet, 7/24/20)
Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States — The NIH RADx Initiative (NEJM, 7/22)
Comparison of Unsupervised Home Self-collected Midnasal Swabs With Clinician-Collected Nasopharyngeal Swabs for Detection of SARS-CoV-2 Infection (JAMA Network Open 7/22/20)
First Molecular Profiles of Severe COVID-19 Infections (NIH 6/9/20)
more... less...

To ensure that people with coronavirus disease 2019 (COVID-19) get the care they need, it would help if a simple blood test could predict early on which patients are most likely to progress to severe and life-threatening illness—and which are more likely to recover without much need for medical intervention. Now, researchers have provided some of the first evidence that such a test might be possible.
Proteomic and Metabolomic Characterization of COVID-19 Patient Sera (Cell 5/27/20)
Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020 (JAMA 5/18/20)
Will Antibody Tests for the Coronavirus Really Change Everything? (CME Nature 4/18/20)

Unpacking long COVID-19: How real-world data is helping (Arcadia: White Paper 2/2022) Research indicates as many as 1 in 10 people experience lingering symptoms for weeks or months after their initial COVID-19 infection. And with the pandemic still raging, the number of people who may go on to become long COVID-19 patients could have significant implications for public health.
Arcadia worked with the COVID-19 Patient Recovery Alliance to analyze a massive real-world data set to identify potential drivers of the wide range of symptoms that make up long COVID-19.

Aerosol expert: We can't ignore the role of airborne flu spread (Becker's Hospital Review 10/20/21)
Tuberculosis spreads via breath, not just coughs, study shows (Becker's Hospital Review 10/19/21)
A guideline to limit indoor airborne transmission of COVID-19 (PNAS 4/27/21)
FAQs on Protecting Yourself from COVID-19 Aerosol Transmission (Expert Knowledge)
more... less...

Scientists and engineers with many years of collective research experience related to indoor air quality, aerosol science, aerosol disease transmission, and engineered control systems for aerosols. Our contributors are active researchers investigating aerosol transmission of COVID-19 (see e.g. 1, 2, 3, and 4). Five of us were speakers at the recent Workshop on Airborne Transmission of COVID-19, organized by the US National Academies of Sciences, Engineering, and Medicine (the highest level scientific organization in the US). Three of us are members of a COVID-19 WHO expert group.
Why some people are superspreaders and how the body emits coronavirus (National Geographic 10/27/20)
The TRUTH of How Coronavirus Spreads and How to Prevent Coronavirus | Airborne Transmission (Dr. Mike Hansen, COVID-19 ICU Doctor, 7/16/20 18 min)
more... less...

Let’s face it, there is a reason why hospitals with designated COVID-19 areas require everyone to wear an N95 respirator mask, as well as eye goggles. That’s because we know that this virus has the potential for airborne transmission. During normal breathing and speech, tiny particles are emitted mainly from the mouth. These particles can range in size, with the smallest being less than a micron (1 um), and the biggest being over 500 um in diameter.
Covid-19: How the Virus Gets in and How to Block It: Aerosols, Droplets, Masks, Face Shields, & More (UCSF Grand Rounds 7/16/20, Video 1hr 30min)
SARS-CoV-2 Found in Aerosols in Hospital Staff Areas, Public Places; Guidelines Issued on Protecting Healthcare Workers (NEJM Journal Watch 4/27/20)

Artistic rendering of SARS-CoV-2 virus (orange) covered with antibodies (white), generated by an immune B cell (gray) at the bottom left. Credit: iStock/selvanegra

Can Autoimmune Antibodies Explain Blood Clots in COVID-19? (NIH Director's Blog 11/17/20)

LitCovid Database (NLM)

LitCovid is a curated literature hub for tracking up-to-date scientific information about the 2019 novel Coronavirus. This database is produced by the National Library of Medicine/NCBI BioNLP Research Group. Click topics below to access current results for expert search results.

Some LitCovid search tips:

use AND between terms to narrow search results (e.g. lung AND cancer)
use OR between terms to broaden search results (e.g. pediatric OR child OR adolescent)
the database will automatically truncate and mapping for some words (e.g. pediatric will include pediatrics, infants, etc.) but not all
to force an exact phrase use quotations (e.g. "lung cancer"); use with caution (may exclude relevant articles)

Topic Searches by Dignity Health Librarians

More coming soon. Stay tuned!

Setup a Personal PubMed Search Alert

Instructions for Setting Up a COVID-19 Search Alert (CDC)

Dignity Health Libraries COVID-19 Portal: C-19 Research